Remote Monitoring of Cardiac Implantable Electronic Devices: What is the Evidence?

[1]  L. Allen,et al.  Multiple cArdiac seNsors for mAnaGEment of Heart Failure (MANAGE-HF) - Phase I Evaluation of the Integration and Safety of the HeartLogic Multisensor Algorithm in Patients With Heart Failure. , 2022, Journal of cardiac failure.

[2]  J. Brachmann,et al.  Pulmonary artery sensor system pressure monitoring to improve heart failure outcomes (PASSPORT-HF): rationale and design of the PASSPORT-HF multicenter randomized clinical trial , 2022, Clinical Research in Cardiology.

[3]  G. Sinagra,et al.  [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.

[4]  G. Carr-White,et al.  Real‐world evidence in a national health service: results of the UK CardioMEMS HF System Post‐Market Study , 2021, ESC heart failure.

[5]  J. Boehmer,et al.  Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials , 2021, Heart Failure Reviews.

[6]  C. Israel,et al.  2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. , 2021, European heart journal.

[7]  A. Brandes,et al.  Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial , 2021, The Lancet.

[8]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[9]  Akshay S. Desai,et al.  Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial , 2021, The Lancet.

[10]  G. Boriani,et al.  Remote monitoring and telemedicine in heart failure: implementation and benefits , 2021, Current Cardiology Reports.

[11]  J. Silva-Cardoso,et al.  The Future of Telemedicine in the Management of Heart Failure Patients , 2021, Cardiac failure review.

[12]  Akshay S. Desai,et al.  Response by Shavelle et al to Letters Regarding Article, "Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study". , 2021, Circulation. Heart failure.

[13]  I. Nault,et al.  Remote Monitoring of Cardiovascular Implantable Electronic Devices in Canada: Survey of Patients and Device Health Care Professionals , 2020, CJC Open.

[14]  G. Boriani,et al.  Cardiac Electronic Devices: Future Directions and Challenges , 2020, Medical devices.

[15]  J. Brachmann,et al.  Pulmonary artery pressure‐guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS‐HF) , 2020, European journal of heart failure.

[16]  M. Ueda,et al.  Remote Management of Pacemaker Patients With Biennial In-Clinic Evaluation , 2020, Circulation. Arrhythmia and electrophysiology.

[17]  J. Morgan,et al.  Impact of remote monitoring on clinical outcomes for patients with heart failure and atrial fibrillation: results from the REM‐HF trial , 2020, European journal of heart failure.

[18]  M. Motwani,et al.  Triage‐HF Plus: a novel device‐based remote monitoring pathway to identify worsening heart failure , 2019, ESC heart failure.

[19]  P. Tsai,et al.  Heart Rate Variability and Risk of All-Cause Death and Cardiovascular Events in Patients With Cardiovascular Disease: A Meta-Analysis of Cohort Studies , 2019, Biological research for nursing.

[20]  S. Anker,et al.  Remote monitoring of implantable cardioverter-defibrillators and resynchronization devices to improve patient outcomes: dead end or way ahead? , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[21]  Florentino Lupercio,et al.  Current and Future Use of Insertable Cardiac Monitors. , 2018, JACC. Clinical electrophysiology.

[22]  J. Deharo,et al.  [2018 ESC Guidelines for the diagnosis and management of syncope]. , 2018, Kardiologia polska.

[23]  Michael Cao,et al.  HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: Results From the MultiSENSE Study , 2018, Circulation. Heart failure.

[24]  Christophe Leclercq,et al.  2018 ESC Guidelines for the diagnosis and management of syncope , 2018, European heart journal.

[25]  Rajiv Mahajan,et al.  Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis , 2018, European heart journal.

[26]  N. Varma,et al.  Remote Monitoring for Chronic Disease Management: Atrial Fibrillation and Heart Failure. , 2018, Cardiac electrophysiology clinics.

[27]  J. Pevnick,et al.  Wearable technology for cardiology: An update and framework for the future. , 2018, Trends in cardiovascular medicine.

[28]  Harry Hemingway,et al.  Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals , 2017, The Lancet.

[29]  J. Healey,et al.  Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation , 2018 .

[30]  S. Sarkar,et al.  Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population. , 2017, International journal of cardiology.

[31]  M. Link,et al.  2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2017, Journal of the American College of Cardiology.

[32]  Daniel E Forman,et al.  2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2017, Heart rhythm.

[33]  N. Hawkins,et al.  Long-term complications, reoperations and survival following cardioverter-defibrillator implant , 2017, Heart.

[34]  Haran Burri,et al.  Is There a Future for Remote Cardiac Implantable Electronic Device Management? , 2017, Arrhythmia & electrophysiology review.

[35]  Wojciech Zareba,et al.  2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. , 2017, Heart rhythm.

[36]  J. Morgan,et al.  Remote management of heart failure using implantable electronic devices , 2017, European heart journal.

[37]  Akshay S. Desai,et al.  Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in "Real-World" Clinical Practice. , 2017, Journal of the American College of Cardiology.

[38]  A. Capucci,et al.  Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT , 2017, European heart journal.

[39]  A. Lazarus,et al.  Early Detection and Treatment of Atrial Arrhythmias Alleviates the Arrhythmic Burden in Paced Patients: The SETAM Study , 2017, Pacing and clinical electrophysiology : PACE.

[40]  M. Yoshiyama,et al.  A case of unexpected early battery depletion caused by lithium cluster formation in implantable cardioverter-defibrillator. , 2017, Journal of cardiology cases.

[41]  Yi Zhang,et al.  A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study. , 2017, JACC. Heart failure.

[42]  Haran Burri,et al.  Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE‐CARE multicentre randomized controlled trial , 2017, European journal of heart failure.

[43]  P. Sanders,et al.  In-office insertion of a miniaturized insertable cardiac monitor: Results from the Reveal LINQ In-Office 2 randomized study. , 2017, Heart rhythm.

[44]  Gianluigi Savarese,et al.  Global Public Health Burden of Heart Failure. , 2016, Cardiac failure review.

[45]  W. Abraham,et al.  Pulmonary artery pressure‐guided heart failure management: US cost‐effectiveness analyses using the results of the CHAMPION clinical trial , 2016, European journal of heart failure.

[46]  Richard L. Verrier,et al.  ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiacmonitoring / telemetry , 2017 .

[47]  Adrian F Hernandez,et al.  Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Registry. , 2016, Circulation. Heart failure.

[48]  M. Wajngarten,et al.  Silent Atrial Fibrillation in Elderly Pacemaker Users: A Randomized Trial Using Home Monitoring , 2016, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[49]  R. Furlan,et al.  Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope. , 2016, The Cochrane database of systematic reviews.

[50]  A. Aggarwal,et al.  Accelerated Implantable Defibrillator Battery Depletion Secondary to Lithium Cluster Formation: A Case Series , 2016, Pacing and clinical electrophysiology : PACE.

[51]  Michael Böhm,et al.  Fluid status telemedicine alerts for heart failure: a randomized controlled trial. , 2016, European heart journal.

[52]  Peter M. Rothwell,et al.  Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report , 2016, Journal of the American Heart Association.

[53]  Catherine Klersy,et al.  Effect of telemonitoring of cardiac implantable electronic devices on healthcare utilization: a meta‐analysis of randomized controlled trials in patients with heart failure , 2016, European journal of heart failure.

[54]  L. Stevenson,et al.  Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial , 2016, The Lancet.

[55]  R. Passman,et al.  Uncovering Atrial Fibrillation Beyond Short-Term Monitoring in Cryptogenic Stroke Patients: Three-Year Results From the Cryptogenic Stroke and Underlying Atrial Fibrillation Trial , 2016, Circulation. Arrhythmia and electrophysiology.

[56]  Roberto Ferrari,et al.  Remote monitoring of implantable devices: Should we continue to ignore it? , 2016, International journal of cardiology.

[57]  R. Mahajan,et al.  Remote Monitoring of Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Clinical Outcomes. , 2015, Journal of the American College of Cardiology.

[58]  A. Capucci,et al.  Remote monitoring improves outcome after ICD implantation: the clinical efficacy in the management of heart failure (EFFECT) study. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[59]  F. Martinez,et al.  Heart failure and respiratory hospitalizations are reduced in patients with heart failure and chronic obstructive pulmonary disease with the use of an implantable pulmonary artery pressure monitoring device. , 2015, Journal of cardiac failure.

[60]  J. Daubert,et al.  Novel mechanism of premature battery failure due to lithium cluster formation in implantable cardioverter-defibrillators. , 2014, Heart rhythm.

[61]  William T. Abraham,et al.  Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection Fraction , 2014, Circulation. Heart failure.

[62]  J. Healey,et al.  2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation. , 2014, The Canadian journal of cardiology.

[63]  G. Hindricks,et al.  Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial , 2014, The Lancet.

[64]  Frank Beckers,et al.  Cryptogenic stroke and underlying atrial fibrillation. , 2014, The New England journal of medicine.

[65]  V. Chair,et al.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.

[66]  R. Pachulski,et al.  Implant Evaluation of an Insertable Cardiac Monitor Outside the Electrophysiology Lab Setting , 2013, PloS one.

[67]  Piotr Ponikowski,et al.  EURObservational Research Programme: regional differences and 1‐year follow‐up results of the Heart Failure Pilot Survey (ESC‐HF Pilot) , 2013, European journal of heart failure.

[68]  Dominique Lacroix,et al.  A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial , 2012, European heart journal.

[69]  Bernhard Reimers,et al.  Current and Emerging Indications for Implantable Cardiac Monitors , 2012, Pacing and clinical electrophysiology : PACE.

[70]  Peter C Austin,et al.  Lifetime Analysis of Hospitalizations and Survival of Patients Newly Admitted With Heart Failure , 2012, Circulation. Heart failure.

[71]  A. Capucci,et al.  Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.

[72]  M. Borggrefe,et al.  Intrathoracic Impedance Monitoring, Audible Patient Alerts, and Outcome in Patients With Heart Failure , 2011, Circulation.

[73]  A. Brandes,et al.  Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[74]  P. Heidenreich,et al.  Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study , 2010, Circulation.

[75]  R. Schweikert,et al.  Automatic Remote Monitoring of Implantable Cardioverter-Defibrillator Lead and Generator Performance: The Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) Trial , 2010, Circulation. Arrhythmia and electrophysiology.

[76]  R. Schweikert,et al.  Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial , 2010, Circulation.

[77]  Dominique Lacroix,et al.  Contributions of remote monitoring to the follow-up of implantable cardioverter–defibrillator leads under advisory , 2010, European heart journal.

[78]  Gillian D Sanders,et al.  Remote Monitoring of Implantable Cardioverter Defibrillators versus Quarterly Device Interrogations in Clinic: Results from a Randomized Pilot Clinical Trial , 2010, Journal of cardiovascular electrophysiology.

[79]  P. Adamson,et al.  Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: New insights from continuous monitoring devices , 2009, Current heart failure reports.

[80]  Dongfeng Qi,et al.  The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study , 2009, Circulation. Arrhythmia and electrophysiology.

[81]  E. Aliot,et al.  Indications for the use of diagnostic implantable and external ECG loop recorders. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[82]  C. Lau,et al.  Intrathoracic Impedance Monitoring in Patients With Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization , 2005, Circulation.

[83]  G. Lamas,et al.  Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST) , 2003, Circulation.

[84]  R Yee,et al.  Randomized Assessment of Syncope Trial: Conventional Diagnostic Testing Versus a Prolonged Monitoring Strategy , 2001, Circulation.